Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? by Haddad, FS et al.
SYMPOSIUM: 2014 KNEE SOCIETY PROCEEDINGS
Is Single-stage Revision According to a Strict Protocol Effective
in Treatment of Chronic Knee Arthroplasty Infections?
Fares Sami Haddad FRCS (Tr&O), Mohamed Sukeik MRCSEd,
Sulaiman Alazzawi MRCSEd
Published online: 13 June 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Background The increasing number of patients experi-
encing periprosthetic total knee arthroplasty (TKA)
infections and the cost of treating them suggest that we
seek alternatives to two-stage revision. Single-stage revi-
sion is a potential alternative to the standard two-stage
procedure because it involves only one surgical procedure,
so if it is comparably effective, it would be associated with
less patient morbidity and lower cost.
Questions/purposes We compared (1) the degree to
which our protocol of a highly selective single-stage revi-
sion approach achieved infection control compared with a
two-stage revision approach to TKA infections; and (2)
Knee Society scores and radiographic evidence of implant
fixation between the single-stage and two-stage patients
who were treated for more complicated infections.
Methods Between 2004 and 2009, we treated 102 patients for
chronic TKA infections, of whom 28 (27%) were treated using
a single-stage approach and 74 (73%) were treated using a two-
stage approach. All patients were available for followup at a
minimum of 3 years (mean, 6.5 years; range, 3–9 years). The
indications for using a single-stage approach were minimal/
moderate bone loss, the absence of immunocompromise,
healthy soft tissues, and a known organism with known sen-
sitivities for which appropriate antibiotics are available.
Participants included 38 men and 64 women with a mean age of
65 years (range, 45–87 years). We used the Musculoskeletal
Infection Society definition of periprosthetic joint infection to
confirm infection control at the last followup appointment.
Radiographs were evaluated for signs of loosening, and
patients completed Knee Society Scores for clinical evaluation.
Results None of the patients in the single-stage revision
group developed recurrence of infection, and five patients
(93%) in the two-stage revision group developed reinfection
(p = 0.16). Patients treated with a single-stage approach
had higher Knee Society scores than did patients treated
with the two-stage approach (88 versus 76, p \ 0.001).
However, radiographic findings showed a well-fixed pros-
thesis in all patients with no evidence of loosening at last
followup in either group.
Conclusions Our data provide preliminary support to the
use of a single-stage approach in highly selected patients
with chronically infected TKAs as an alternative to a two-
stage procedure. However, larger, multicenter, prospective
trials are called for to validate our findings.
Level of Evidence Level III, therapeutic study. See
Instructions for Authors for a complete description of
levels of evidence.
Introduction
Most TKA studies today report infection in fewer than 2%
of primary and 5% of revision procedures [16, 22, 34, 35].
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Nevertheless, both diagnosis and management of peri-
prosthetic TKA infections remain challenging because the
ability to detect and eradicate pathogens in periarticular
structures and the magnitude of the host response to
infection vary with the virulence of the infecting organism
and the immunocompetence of the host [12]. Management
depends on a number of factors including the acuteness or
chronicity of the infection, the infecting organism and its
sensitivity profile to antibiotics, the health of the patient,
the fixation of the prosthesis, available bone stock, and the
particular philosophy and training of the surgeon [12, 23,
37].
Two-stage revision remains the standard for treatment of
chronic TKA infections because many series report the
successful eradication of a periprosthetic joint infection
(PJI) in more than 90% of patients using this approach [12,
16, 38]. Furthermore, it permits the use of allografts, which
is particularly important given the frequency of femoral
and tibial defects associated with TKA infections [14, 17].
Nevertheless, this procedure is costly, time-consuming, and
may result in increased damage to bone and surrounding
soft tissues [35].
Single-stage revision in selected cases has become an
appealing alternative because it involves only one surgical
procedure and, if comparably effective, will be associated
with less patient morbidity and potentially improved
functional outcomes and less expense [11, 24, 35]. Infec-
tion control using a single-stage strategy in selected
patients is achieved in 67% to 95% of patients [4, 10, 20,
30–32, 36].
At our institution, we carry out single-stage TKA revi-
sions for chronic infections in very selected circumstances
and, therefore, we determined in this study (1) the degree to
which our protocol of a highly selective single-stage revi-
sion approach achieved infection control compared with a
two-stage revision approach to TKA infections; and (2)
Knee Society scores and radiographic evidence of implant
fixation between the single-stage and two-stage patients
who were treated for more complicated infections.
Patients and Methods
Between 2004 and 2009, we treated 102 patients for chronic
TKA infections, of whom 28 (27%) were treated using a
single-stage approach and 74 (73%) were treated using a
two-stage approach. All patients were available for followup
at a minimum of 3 years (mean, 6.5 years; range, 3–9 years).
In the two-stage revision group, 12 patients had under-
gone two and 24 undergone one previous aseptic revision.
There were no prior revision procedures in the remaining
38 patients. In the single-stage group, eight patients had
undergone aseptic revisions and the rest were primaries.
At our institution, a patient with suspected TKA infec-
tion is promptly referred to the knee surgeons who deal
with PJIs regularly because this is a specialized procedure
and there is no role for simple incision and drainage or
repetitive washouts, which result in emergence of resistant
microorganisms [35]. Clinical presentation (pain, fever,
swelling, skin redness, discharging sinus), serologic testing
(erythrocyte sedimentation rate [ESR] [ 30 mm/hour;
C-reactive protein [CRP] [ 10 mg/L), knee aspiration, and
biopsy samples help us diagnose PJI [33, 35]. Definitive
diagnosis, however, is established when three to six spec-
imens are sampled from different sites at the time of
surgery (eg, capsule, femur and tibia) and the same
microorganism is cultured from at least three specimens
[2, 35, 37].
A decision to perform surgery was based on either
growing a microorganism from the tissue aspiration/biop-
sies or presence of a sinus tract communicating with the
prosthesis. A microorganism was identified preoperatively
in all single-stage patients and in 65 of the two-stage
patients, whereas the remaining nine patients were identi-
fied postoperatively only despite the presence of a
discharging sinus in five patients. The remaining four
patients had compelling evidence of PJI with elevated
inflammatory markers, loose prostheses, and purulence on
aspiration of the joints despite the absence of an isolated
microorganism.
We graded all patients according to a standardized
protocol for chronic hip and knee PJIs based on the criteria
previously set out by Haddad et al. [13] and considered
them for either a single- or two-stage revision procedure
accordingly (Table 1). The indications for using a single-
stage approach during the period in question included (1)
insignificant bone loss (eg, Anderson Type I and II defects
[6, 7]) or a soft tissue defect that could be closed primarily;
(2) nonimmunosuppressed hosts: patients who are not
rheumatoid or diabetic or on immunosuppressant medica-
tion and did not have ongoing sepsis elsewhere or chronic
disease such as anemia or cancer; and (3) isolation of a
single low virulent organism preoperatively, which is
sensitive to bactericidal antibiotic treatment. Hence, we
excluded polymicrobial infections and multiresistant
organisms such as methicillin-resistant Staphylococcus
aureus and methicillin-resistant Staphylococcus epidermi-
dis and included appropriate patients only after discussion
with our microbiologist colleagues. If patients had any of
the contraindications (Table 1), they underwent a two-
stage revision instead.
Participants included 28 patients in the single-stage
group with a mean age of 63 years (range, 48–87 years)
and equal distribution of 14 women and men. On the other
hand, the two-stage group included 74 patients with a mean
age of 68 years (range, 45–85 years) of whom 41 were
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women and 33 were men. Overall there were 12 patients with
sinus tracts communicating with the prosthesis all in the two-
stage group. No bilateral infections were included in our
study. No patient had a history of infection of the affected
knee. The majority of patients had osteoarthritis as the
underlying pathology for their primary TKA (74 patients)
followed by inflammatory arthropathy (20 patients) and
posttraumatic/acute vascular necrosis resulting in secondary
osteoarthritis in eight patients. In patients who had under-
gone revision TKA, the original indications for reoperation
after their primary procedures were aseptic loosening and
wear. Comorbidities were assessed according to the Amer-
ican Society of Anesthesiologists grading system [19]; nine
patients were Grade I, 56 Grade II, and 37 Grade III. Three
patients died during the followup period but had a minimum
of 2 years’ data available for analysis. No patients were
recalled specifically for this study; all data were obtained
from medical records and radiographs.
Surgical Technique: Single-stage Revision
The operation consists of open aggressive de´bridement
with removal of all components and cement, during which
multiple samples are sent to microbiology before admin-
istration of antibiotics and the knee is irrigated with
hydrogen peroxide and Betadine1 solutions (Videne,
Ecolab Ltd, Swindon, UK) and pulsatile lavage. The
wound is then soaked in aqueous Betadine1 and the wound
edges are approximated. The patient is then redraped, the
surgical team rescrubs, and new instruments are used. After
a further lavage, implantation of a new prosthesis is per-
formed using antibiotic-loaded cement (ALC) according to
known sensitivities at a volume of \ 5% of the total weight
of cement powder. For example, we commonly used 1 g
vancomycin and 1 g gentamicin per 40-g bag of Palacos1R
(Heraeus Medical, Wehrheim, Germany) for our single-
stage revisions. Postoperatively, patients continue antibi-
otic therapy tailored to the sensitivities of intraoperative
cultures for at least 6 weeks until inflammatory markers
(CRP, ESR) and nutritional markers such as plasma albu-
min concentration return to stable limits (levels normalized
in 90% of cases). Normal levels were defined as an
ESR \ 30 mm/hour, CRP \ 10 mg/L, and albumin 35 to
50 g/L. The change from intravenous to oral therapy is
effected as soon as we have a full organism sensitivity
profile and after consultation with our infectious diseases
team with whom we have a fortnightly multidisciplinary
meeting (IV antibiotics for 1 week: four patients, 2 weeks:
seven patients, 6 weeks: 17 patients). Long-term oral
suppressive antibiotic therapy was not used in any patients
after IV treatment had concluded.
Surgical Technique: Two-stage Revision
Intraoperatively, the first part of the operation is similar to
a single-stage revision. However, after rescrubbing and
redraping, a temporary articulating ALC spacer is
implanted instead. This spacer normally contains 3 g
vancomycin and 2 g gentamicin per sachet of Palacos1R
(Heraeus Medical), which provides a broad spectrum of
coverage for organisms commonly encountered with deep
periprosthetic infections while reducing the development
of resistant strains [1]. Postoperatively, the patient is
allowed to mobilize partial weightbearing with crutches
and is discharged home when deemed safe. All patients had
IV antibiotics for the first 5 days and then either IV or oral
antibiotic therapy was continued and tailored to the sensi-
tivities of intraoperative cultures and continued for
6 weeks (seven patients had 2 weeks of IV and then oral
antibiotics, five had 6 weeks of IV antibiotics). The deci-
sion to proceed with insertion of a new prosthesis is
determined by the clinical response of the patient including
wound healing and inflammatory and nutritional markers
indicating resolution of infection, which is confirmed after
2 weeks of discontinuing any antibiotics the patient was
taking. At the second stage, the spacer is removed and the
underlying cement mantle is fragmented and removed
piecemeal without sacrificing bone stock. An appropriate
prosthesis is then reimplanted with cemented components,
and allografts may be used in cases of severe bone loss.
Types of implants and augments used are listed (Table 2).
Table 1. Contraindications for single-stage revision THA and TKA
Category Compromising factor
Local Significant soft tissue compromise
Significant bone loss precluding cemented
reconstruction
Peripheral vascular disease
Host Immunosuppression
Concurrent sepsis
Systemic disease
Reinfection
Organism Multiresistant organisms MRSA/MRSE
Polymicrobial infection
Unusual commensals
Unusual resistance profiles
Unidentified infective organisms
Reproduced with permission and copyright  of the British Editorial
Society of Bone and Joint Surgery [Oussedik SI, Dodd MB, Haddad
FS. Outcomes of revision total hip replacement for infection after
grading according to a standard protocol. J Bone Joint Surg Br.
2010;92:1222–1226]; MRSA = methicillin-resistant Staphylococcus
aureus; MRSE = methicillin-resistant Staphylococcus epidermidis.
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Regardless of the treatment strategy followed, we
review all our patients postoperatively at 6 weeks,
6 months, 1 year, and then on a yearly basis looking for
clinical symptoms and signs of infection as well as CRP
and ESR. One of us (FSH) performed all the procedures.
We obtain plain radiographs including AP, lateral, and
skyline views of both knees at every followup appointment.
We assess component position, radiolucencies/osteolysis,
and loosening according to The Knee Society recommen-
dations [8, 29]. Distinguishing infective loosening from
aseptic loosening radiographically can be difficult; how-
ever, signs of an infected knee arthroplasty include
progressively enlarging lucencies, endosteal scalloping,
periostitis, and focal lysis [29].
Control of infection is defined as absence of clinical,
serologic, and radiographic signs of infection and absence
of death secondary to infection or treatment during the
followup period. We used the Musculoskeletal Infection
Society criteria in our last outpatient review to assess and
confirm infection control [26, 27]. We define failure as any
major operation performed in any subgroup of patients for
control of infection, including a two-stage revision, exci-
sion arthroplasty, arthrodesis, and amputation, or the need
for long-term antibiotic suppression. We consider reinfec-
tion to be an infection with the same or another organism.
The mean interval time between each stage was 62 days
(range, 42–119 days). Duration of antibiotic treatment was
63 days (range, 42–85 days) for the single-stage group and
12 days (range, 5–42 days) for the two-stage group.
The causative microorganism was identified preopera-
tively in all single-stage patients and in 65 of the two-stage
patients, whereas the remaining nine patients were identi-
fied postoperatively. Microbiology from intraoperative
tissue sampling confirmed bacterial infection in all patients
with the most commonly isolated organism being coagu-
lase-negative Staphylococcus (34 patients [33%]) of which
nine were methicillin-resistant followed by S aureus (33
patients [32%]), of which 11 were methicillin-resistant
(Table 3). Other microorganisms isolated included Gram-
negatives (17 patients), Streptococcus (16 patients),
anaerobes (eight patients), and Candida and Mycobacteria
(four patients). Ten patients had polymicrobial infections.
Most common reinfections were the result of polymicrobial
infections (Fig. 1).
The functional outcome for all patients was evaluated
using the Knee Society scoring system, which was recor-
ded preoperatively and at the 2-year followup.
Statistical analysis was carried out using the two-sample
t-test or Mann-Whitney U test for continuous outcomes and
a chi-square test or Fisher’s exact test for categorical
outcomes.
Results
None of the patients in the single-stage revision group
developed recurrence of infection, and five patients (7%) in
the two-stage revision group developed reinfection
(p = 0.16). Those patients, however, underwent a further
two-stage revision procedure and had their infections
controlled at last followup.
The Knee Society score was higher in the single-stage
group at 2 years than in the two-stage group (mean, 88;
range, 38–97 versus 76; range, 29–93; p \ 0.001). Both
groups improved in this score after successful reconstruc-
tion from a mean of 32 (range, 18–65) to a mean of 88
(range, 38–97) in the single-stage group and 31 (range,
17–70) to 76 (range, 29–93) in the two-stage group
(Table 4). Radiographic findings showed a well-fixed
prosthesis in all patients of both groups with no evidence of
loosening at the most recent followup.
Discussion
Despite the relatively low rates of PJIs after TKAs, they
remain a leading cause of revision surgery as a result of an
Table 2. Types of implants/reconstructions used for the single- and
two-stage revisions of infected TKAs
Type of implant/
reconstruction
Number of single-
stage revisions
Number of two-
stage revisions
Augments 4 9
Cones 2 5
Stems on one side or both 28 74
Semiconstrained implants 18 50
Hinges 7 19
Bone graft 0 6
Table 3. Microorganisms grown from intraoperative tissue biopsies
Microorganism Number of
single-
stage
revisions
Number of
two-
stage
revisions
Staphylococcus aureus
(methicillin-resistant S. aureus)
8
(0)
25
(11)
Coagulase-negative Staphylococcus 11 23
(methicillin-resistant Staphylococcus
epidermidis)
(0) (9)
Streptococcus 4 12
Gram-negatives 4 13
Anaerobes 1 7
Candida/Mycobacteria 0 4
Polymicrobial 0 10
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ever increasing number of knee arthroplasties performed
yearly for an aging population [12, 35]. In contrast to two-
stage revisions, single-stage surgery may offer a shorter
hospital stay, the avoidance of complications associated
with a second operation, improved postoperative function
and pain, and lower cost; however, whether infection
control is sacrificed for these endpoints remains contro-
versial, and if it is, a single-stage approach would likely not
be justified. In this study, we therefore determined (1) the
degree to which our protocol of a highly selective single-
stage revision approach achieved infection control com-
pared with a two-stage revision approach to TKA
infections; and (2) Knee Society scores and radiographic
evidence of implant fixation between the single-stage and
two-stage patients who were treated for more complicated
infections.
Our study is associated with some limitations. First, a
single-stage revision procedure was applied in a highly
selected patient population using the indications we have
defined (Table 1) and is not suitable for ‘‘all comers.’’
Second, patients undergoing two-stage procedures tend to
have been more complicated taking into consideration that
they had undergone multiple revision procedures and had
less bone stock to start off with, which may account for the
more complex reconstructions and the higher observed
Knee Society scores in the single-stage patients. Third, 3
years of followup is not sufficient to know that these
patients will remain without infections; there is a risk of
infection recurring, and hence our close followup continues
for this cohort of patients. Fourth, infection control after
knee arthroplasties can be affected by a number of risk
factors, including age, sex, time from operation, duration of
symptoms, patient comorbidities, and the pathogen causing
the infection [5, 12, 35]. Because of the small number of
patients within each subgroup, the heterogeneity of the
study population (type of original operation, number of
previous surgeries, and type of surgery performed) and the
observational nature of this study, we were unable to per-
form a multivariate analysis to further investigate the effect
of those risk factors on infection control outcome. Fifth,
despite no recurrence of infection in the single-stage group
of patients, the numbers included in this study remain
small. This, however, reflects the difficulty of finding large
numbers suitable for a single-stage revision even at a ter-
tiary center dealing with significant numbers of
periprosthetic infections.
Our results for infection control using two-stage revision
for chronic infections are consistent with those previously
reported in the literature, especially where a clear protocol
has been followed [3, 9, 12, 15, 16, 18, 21, 28, 38]. It is of
note, however, that the inclusion and exclusion criteria as
well as management protocols varied among those studies,
occasionally including all four types of periprosthetic
infections rather than chronic infections only. Additionally,
0
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Fig. 1 Microorganisms responsible for infections and reinfections are shown. CNS = coagulase-negative Staphylococcus.
Table 4. Knee Society scores and visual analog scale satisfaction
scores
Outcomes Single-stage Two-stage p value
Number of patients 28 74 N/A
Recurrent infection 0 5 \ 0.01
KSS preoperatively 32 (18–65) 31 (17–70) NS
KSS at 2 years 88 (38–97) 76 (29–93) \ 0.02
Difference in KSS 56 45 \ 0.02
Visual analog scale at 2 years 7.82 6.18 \ 0.01
Ranges in parentheses; KSS = Knee Society score; N/A = not
applicable; NS = not significant.
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some of the studies did not differentiate between knees and
hips when reporting their results, which resulted in a wide
range of infection control rates. On the other hand, single-
stage revisions for chronic infections are regaining
momentum and our results certainly reflect a strict protocol,
which has led to superior results to what has been reported in
the literature [4, 10, 20, 30–32, 36] (Table 5). The only study
with equivalent results to our study reporting 100% infection
control with a single-stage strategy was recently published
by Parkinson et al. [25]. However, in their 12-patient series,
they did not mention details about the inclusion criteria for
their protocol apart from growing a microorganism from the
arthroscopy performed preoperatively for a diagnosis of
infection. Additionally, there are no details regarding the
type of infection treated (acute or chronic, postoperative or
hematogenous).
Other studies also reported improvement in Knee
Society scores after a single-stage revision for PJI. For
example, Singer et al. [31] reported a mean Knee
Society score of 72 points after 24 months and a mean
reported range of movement of 104. Buechel et al. [4]
also had a similar mean final postoperative knee score of
79.5 (range, 35–94). This may support an easier conva-
lescence as a potential advantage of a single-stage
procedure, especially with no differences found in pros-
thesis fixation as seen in our current study at the latest
followup.
In conclusion, our data support the use of single-stage
revision surgery in chronic TKA infections as an alternative
to a two-staged procedure with high infection control rates
when patients are carefully selected. However, larger, mul-
ticenter, prospective trials are called for to validate our
findings.
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